Your browser doesn't support javascript.
loading
Repurposing the oncolytic virus VSV∆51M as a COVID-19 vaccine.
Alkayyal, Almohanad A; Darwish, Manar; Ajina, Reham; Alabbas, Saleh Y; Alotaibi, Mohammed A; Alsofyani, Abeer; Bokhamseen, Maha; Hakami, Maumonah; Albaradie, Omar A; Moglan, Abdulaziz M; Hala, Sharif; Alsahafi, Abdullah Faisal; Zakri, Samer; Almuzaini, Adnan; Alsharari, Khamis; Kaboha, Feras; Taher, Mustafa Y; Zein, Haggag S; Alroqi, Fayhan; Mahmoud, Ahmad Bakur.
  • Alkayyal AA; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia.
  • Darwish M; Immunology Research Program, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Ajina R; Immunology Research Program, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Alabbas SY; Immunology Research Program, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Alotaibi MA; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alsofyani A; Immunology Research Program, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Bokhamseen M; Immunology Research Program, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Hakami M; Department of Cellular Therapy and Cancer Research, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
  • Albaradie OA; King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
  • Moglan AM; Immunology Research Program, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Hala S; Immunology Research Program, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Alsahafi AF; Immunology Research Program, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Zakri S; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
  • Almuzaini A; Immunology Research Program, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Alsharari K; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
  • Kaboha F; King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
  • Taher MY; Infectious Disease Research Department, King Abdullah International Medical Research Centre, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
  • Zein HS; King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
  • Alroqi F; Infectious Disease Research Department, King Abdullah International Medical Research Centre, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
  • Mahmoud AB; King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
Front Bioeng Biotechnol ; 11: 1150892, 2023.
Article en En | MEDLINE | ID: mdl-37528991